Know Cancer

or
forgot password

    • cancer clinical trials in corpus christi, TX

    • Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
    Cancer Specialists of South Texas
    Corpus Christi, Texas 78412
    Breast Cancer, Neutropenia
    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
    Cancer Specialists of South Texas

    Trial Locations
    Cancer Specialists of South Texas
    Coastal Bend Cancer Center
    Breast Neoplasms
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    South Texas Cancer Center
    Corpus Christi, Texas 78405
    Metastatic Breast Cancer
    Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Coastal Bend Cancer Center
    Corpus Christi, Texas 78404
    Non-Small Cell Lung Cancer
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 073
    Corpus Christi, Texas 78414
    Hypoactive Sexual Desire Disorder
    Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
    Site Reference ID/Investigator# 75295
    Corpus Christi, Texas 78404
    Ovarian Cancer, Primary Peritoneal Cancer
    Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib
    South Texas Institute of Cancer S. Tex Inst.- Corpus Christi
    Corpus Christi, Texas 78405
    Chronic Myelogenous Leukemia - Chronic Phase
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    Driscoll Children's Hospital
    Corpus Christi, Texas 78466
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Driscoll Children's Hospital
    Corpus Christi, Texas 78466
    Unspecified Childhood Solid Tumor, Protocol Specific
    Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
    Advanced Research Associates
    Corpus Christi, Texas 78414
    Uterine Fibroids, Anemia
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Coastal Bend Cancer Center
    Corpus Christi, Texas 78404
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
    Coastal Bend Cancer Center
    Corpus Christi, Texas 78404
    Non-small-cell Lung Cancer
    A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
    Coastal Bend Cancer Center
    Corpus Christi, Texas 78404
    Renal Cell Carcinoma
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    Cancer Specialists of South Texas, P.A.
    Corpus Christi, Texas 78412
    Chemotherapy-Induced Nausea and Vomiting
    A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    South Texas Institute of Cancer
    Corpus Christi, Texas 78405
    Chemotherapy-Induced Nausea and Vomiting